Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2019

01-12-2019 | Care | ASO Author Reflections

ASO Author Reflections: Better Understanding of What We Have Learned from Cancer Care Quality Metrics

Author: Lawrence N. Shulman, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2019

Login to get access

Excerpt

Prior to 2000, there were very few metrics that analyzed the quality of cancer care in the USA. We assumed that the quality of cancer care delivered in the USA was excellent, but there were little data to support this. Recently, it has been shown that cancer outcomes in the USA are quite variable across hospital types, though the reasons for this are poorly understood.1,2 Eventually, we acknowledged that, without measurement, you could neither evaluate quality nor improve performance. In the early 2000s, the Commission on Cancer began to institute cancer care quality metrics derived from the National Cancer Data Base and return the results to all of its accredited cancer programs.3 …
Literature
1.
Shulman LN, Palis BE, McCabe R, Mallin K, Loomis A, Winchester D, McKellar D. Survival as a quality metric of cancer care: use of the National Cancer Data Base to assess hospital performance. J Oncol Pract 2018;14(1):e59–72.CrossRef
2.
Pfister DG, Rubin DM, Elkin EB, Neill US, Duck E, Radzyner M, Bach PB. Risk adjusting survival outcomes in hospitals that treat patients with cancer without information on cancer stage. JAMA Oncol 2015;1(9):1303–10.CrossRef
3.
4.
Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 2006;244(4):602–10.PubMedPubMedCentral
5.
Shulman LN, Browner AE, Palis BE, Mallin K, Kakade S, Carp N, McCabe R, Winchester D, Wong SL, McKellar DP. Compliance with cancer quality measures over time and their association with survival outcomes: the Commission on Cancer’s experience with the quality measure requiring at least 12 regional lymph nodes to be removed and analyzed with colon cancer resections. Ann Surg Oncol 2019; 26:1613–21.CrossRef
Metadata
Title
ASO Author Reflections: Better Understanding of What We Have Learned from Cancer Care Quality Metrics
Author
Lawrence N. Shulman, MD
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07524-3

Other articles of this Special Issue 3/2019

Annals of Surgical Oncology 3/2019 Go to the issue

ASO Author Reflections

ASO Author Reflections: Does Genomic Testing of DCIS Provide Added Value? And Is It Worth the Cost?

ASO Author Reflections

ASO Author Reflections: Evaluation of Lymph Nodes by FDG-PET for Esophageal Cancer

ASO Author Reflections

ASO Author Reflections: Prognostic Role of Pathologic Complete Response After Neoadjuvant Therapy in Digestive Cancer

ASO Author Reflections

ASO Author Reflections: Annexin A3 as a Potential Biomarker for Hepatocellular Carcinoma

ASO Author Reflections

ASO Author Reflections: Is It Truly Necessary to Resect the Thoracic Duct in Esophagectomy for Esophageal Cancer?

Health Services Research and Global Oncology

Global Surgical Oncology Efforts Using a Common Language